Condition: Cell Carcinoma · Sponsor: Centre Hospitalier Universitaire de Nice
his is a Phase 2, Single-Arm, Open-Label, Single Center, to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell carcinoma (sBCC) not arising on the face or scalp
This description comes directly from the study's public registry record.
Philippe Bahadoran, PhD · +33492036223 · bahadoran.p@chu-nice.fr
Henri Montaudie, PhD · +33492036223
Always discuss trial participation with your own doctor first.
| CHU de Nice - Hôpital de l'Archet | Nice, Alpes-maritimes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06112522